EUVIMEDEUVIMED entdecken
Crossref

Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer

Ping Tian, Dajun Du, Li Yang, Nan Zhou, Ling Tao

Cell Biochemistry and Biophysics · 2024

DOI: 10.1007/s12013-024-01296-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Ping Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical, Xinyang Vocational and Technical College, Xinyang, 464000, Henan, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, Lentinan, Lung Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Key Research and Development and Promotion Project of Henan Province (Scientific and Technological Project).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmLentinanLung NeoplasmsOxidative StressPemetrexedSignal TransductionHumansAntineoplastic AgentsCell Line, TumorCell ProliferationMembrane Potential, MitochondrialPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesSuperoxide Dismutase

Stichwörter der Autor:innen

LentinanNon-small cell lung cancerOxidative stressPI3K/AktPemetrexed

Substanzen

Antineoplastic AgentsLentinanPemetrexedPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesSuperoxide Dismutase

Autor:innen und Institutionen

  • School of Medical, Xinyang Vocational and Technical College, Xinyang, 464000, Henan, China.
  • Department of Cancer Surgery, Xinyang Central Hospital, Xinyang, 464000, Henan, China.
  • School of Inspection, Xinyang Vocational and Technical College, Xinyang, 464000, Henan, China.
  • Department of Medical Oncology, Xinyang Central Hospital, Xinyang, 464000, Henan, China.
  • School of Inspection, Xinyang Vocational and Technical College, Xinyang, 464000, Henan, China. taolingtl2019@163.com.

Förderung

  • Key Research and Development and Promotion Project of Henan Province (Scientific and Technological Project)

Zitieren

APA

Tian, P., Du, D., Yang, L., Zhou, N., & Tao, L. (2024). Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01296-8

Vancouver

Tian P, Du D, Yang L, Zhou N, Tao L. Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01296-8

BibTeX
@article{Tian2024,
  author = {Tian, Ping and Du, Dajun and Yang, Li and Zhou, Nan and Tao, Ling},
  title = {Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer},
  journal = {Cell Biochemistry and Biophysics},
  year = {2024},
  doi = {10.1007/s12013-024-01296-8}
}
Kostenlos starten →